InsidersTradesSigma
Follow the 카나프테라퓨틱스 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 카나프테라퓨틱스 has recorded 3 public disclosures. Market capitalisation: €162bn. The latest transaction was disclosed on 23 March 2026 (Purchase). Among the most active insiders: 김동건. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Kanap Therapeutics es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en el desarrollo de tratamientos y soluciones terapéuticas innovadoras.